Older Jehovah’s Witnesses with Acute Myeloid Leukemia: Hypomethylating Agents and Venetoclax as a Transfusion-Sparing Approach

The treatment of acute myeloid leukemia (AML) in Jehovah’s Witness (JW) patients poses unique challenges due to their refusal of blood transfusions. This case series reports the outcomes of four older JW patients with AML treated with azacitidine (Aza) and venetoclax (Ven), including two with hyperl...

Descripción completa

Detalles Bibliográficos

Autores principales:	Aditi Sharma, Danielle Blake, Jay Yang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2025-06-01
Colección:	Hemato
Materias:	AML acute myeloid leukemia Jehovah’s Witness venetoclax hypomethylating agent azacitidine
Acceso en línea:	https://www.mdpi.com/2673-6357/6/2/16
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!